Key Points
• The oversight responsibilities for genetic testing in the United States (US) are shared by multiple governmental and non-governmental entities, including federal and state government agencies, healthcare payers, professional associations, and other sectors. This chapter describes:
• The complex array of US oversight mechanisms and responsibilities related to genetic testing and the application of genetic tests and testing information in patient care and health management at the federal, state, and private-sector levels;
• Issues and potential gaps in oversight mechanisms for genetic testing, such as concerns related to analytic validity, clinical validity, external quality assessment, clinical utility, and direct-to-consumer genetic testing; and
• Ongoing efforts to promote quality testing and improve the utilization of genetic testing services in clinical and public health practices
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Advisory Committee on Heritable Disorders in Newborns and Children. Available at: http://www.hrsa.gov/heritabledisorderscommittee/. Health Resources and Services Administration. 2009.
Agency for Healthcare Research and Quality. http://www.ahrq.gov/. 2009.
American College of Medical Genetics. ACMG statement on direct-to-consumer genetic testing. Genet Med 2004; 6: 60.
American College of Medical Genetics. http://www.acmg.net. 2009.
American Society of Human Genetics. http://www.ashg.org/. 2009.
Americans with Disabilities Act of 1990. Available at: http://www.eeoc.gov/ada/adatext.html. 1990.
Association for Molecular Pathology. http://www.amp.org/. 2009.
Association of Public Health Laboratories. Newborn Screening and Genetics. Available at: http://www.aphl.org/aphlprograms/nsg/Pages/default.aspx. Association of Public Health Laboratories. 2009.
California Department of Public Health. California Newborn Screening Program. http://www.cdph.ca.gov/programs/NBS/Pages/default.aspx. 2009a.
California Department of Public Health. Prenatal Screening Branch. http://www.cdph.ca.gov/programs/pns/Pages/default.aspx. 2009b.
Centers for Disease Control and Prevention. Notice of intent; Genetic testing under the clinical laboratory improvement amendments. Federal Regis 2000; 65: 25928–25934.
Centers for Disease Control and Prevention. Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing–Atlanta, Denver, Raleigh-Durham, and Seattle, 2003. Morb Mortal Wkly Rep 2004; 53: 603–606.
Centers for Disease Control and Prevention. Division of Laboratory Systems. Available at: http://wwwn.cdc.gov/dls/default.aspx. 2009a.
Centers for Disease Control and Prevention. Evaluation of Genomic Applications in Practice and Prevention (EGAPP): Implementation and Evaluation of a Model Approach. Available at: http://www.cdc.gov/genomics/gTesting.htm. 2009b.
Centers for Disease Control and Prevention. Good Laboratory Practices for Ensuring the Quality of Molecular Genetic Testing for Heritable Diseases and Conditions. Mor Mortal Wkly Re: 2009; 58(RR-6): 1–37. Available at http://www.cdc.gov/mmwr/pdf/rr/rr5806.pdf
Centers for Medicare & Medicaid Services. Appendix C, Survey Procedures and Interpretive Guidelines for Laboratories and Laboratory Services. Available at: http://www.cms.hhs.gov/CLIA/0_;Interpretive_Guidelines_for_Laboratories.asp#TopOfPage. 2008.
Centers for Medicare & Medicaid Services. Clinical Laboratory Improvement Amendments (CLIA). Available at: http://www.cms.hhs.gov/CLIA/. 2009.
Clinical and Laboratory Standards Institute. http://www.clsi.org/. 2009.
Clinical Laboratory Improvement Advisory Committee (CLIAC). Available at: http://wwwn.cdc.gov/cliac/default.aspx. http://wwwn.cdc.gov/cliac/default.aspx. 2009.
Collaboration, Education, and Test Translation (CETT) Program. Available at: http://www.cettprogram.org/. http://www.cettprogram.org/. 2009.
College of American Pathologists. http://www.cap.org/apps/cap.portal. 2009.
Employee Retirement Income Security Act of 1974. 29 U.S.C. §1001 et seq. Available at: http://www.usdoj.gov/usao/eousa/foia_reading_room/usam/title9/135mcrm.htm. 1974.
Federal Food, Drug, and Cosmetic Act. As amended through 2004. Available at: http://www.fda.gov/opacom/laws/fdcact/fdctoc.htm.
Federal Trade Commission. Facts for Consumers: At-Home Genetic Tests: A Healthy Dose of Skepticism May Be the Best Prescription. Available at: http://www.ftc.gov/bcp/edu/pubs/consumer/health/hea02.shtm. 2006.
Food and Drug Administration. Legal status of approved labeling for prescription drugs; prescribing for uses unapproved by the food and drug administration (Notice of Proposed Rulemaking). Fed Regist 1972; 37: 16503–16505.
Food and Drug Administration. Class II Special Controls Guidance Document: Factor V Leiden DNA Mutation Detection Systems – Guidance for Industry and FDA Staff. Available at: http://www.fda.gov/cdrh/oivd/guidance/1236.html. 2004.
Food and Drug Administration. CFTR Gene Mutation Detection Systems – Guidance for Industry and FDA Staff – Class II Special Controls Guidance Document. Available at: http://www.fda.gov/cdrh/oivd/guidance/1564.html. 2005.
Food and Drug Administration. Guidance for Industry and FDA Staff - Pharmacogenetic Tests and Genetic Tests for Heritable Markers. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfggp/Results.CFM?Doc_Type=1&Doc_IsCur=1&Doc_OFFICE=OIVD&lookandfeel=1&SORT_ORDER=origin,documentdate%20desc. 2007a.
Food and Drug Administration. Guidance for Industry and FDA Staff Commercially Distributed Analyte Specific Reagents (ASRs): Frequently Asked Questions. Available at: http://www.fda.gov/cdrh/oivd/guidance/1590.html. 2007b.
Food and Drug Administration. Draft Guidance for Industry, Clinical Laboratories, and FDA Staff – In Vitro Diagnostic Multivariate Index Assays. Available at: http://www.fda.gov/cdrh/oivd/guidance/1610.html. 2007c.
Food and Drug Administration. FDA News. FDA Clears Breast Cancer Specific Molecular Prognostic Test. Available at: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01555.html. 2007d.
Genetic Alliance. http://www.geneticalliance.org/. 2009.
Genetic Information Nondiscrimination Act of 2008. Public Law No. 110–233, 122 Stat. 881. Available at: http://thomas.loc.gov/cgi-bin/query/z?c110:h493. 2008.
Genetics and Public Policy Center. Survey of direct-to-consumer testing statutes and regulations. Available at: http://www.dnapolicy.org/resources/DTCStateLawChart.pdf. 2007.
Genetics and Public Policy Center. http://www.dnapolicy.org/. 2009.
Genomics and Personalized Medicine Act of 2007 (S.976). Available at: http://www.thomas.gov/cgi-bin/thomas. Introduced in Senate on March 23, 2007.
Gollust SE, Wilfond BS, Hull SC. Direct-to-consumer sales of genetic services on the Internet. Genet Med 2003; 5: 332–337.
Haddow JE, Bradley LA. Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled. Br Med J 1999; 319: 531–532.
Health Insurance Portability and Accountability Act of 1996. Available at: http://aspe.hhs.gov/admnsimp/pl104191.htm. PUBLIC LAW, 104–191.
Holtzman NA, Watson MS. Promoting safe and effective genetic testing in the United States. Final report of the Task Force on Genetic Testing. Available at: http://www.genome.gov/10001733. J Child Fam Nurs 1999; 2(5): 388–390.
Hudson K, Javitt G, Burke W, Byers P. ASHG Statement on direct-to-consumer genetic testing in the United States. Obstet Gynecol 2007; 110: 1392–1395.
Jeffrey GP, Adams PC. Pitfalls in the genetic diagnosis of hereditary hemochromatosis. Genet Test 2000; 4: 143–146.
Laboratory Test Improvement Act (S.736). Available at: http://www.thomas.gov/cgi-bin/thomas. Introduced in Senate on March 1, 2007.
Mouchawar J, et al. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med 2005; 7: 191–197.
National Conference of State Legislatures. State Genetic Privacy Laws. http://www.ncsl.org/programs/health/genetics/prt.htm. 2008.
National Conference of State Legislatures. Legislatures. http://www.ncsl.org/. 2009.
National Institute of Standards and Technology. SRM 2399 – Fragile X Human DNA Triplet Repeat Standard. https://srmors.nist.gov/view_detail.cfm?srm=2399. 2005.
National Institute of Standards and Technology. http://www.nist.gov/. Gaithersburg, MD. 2009.
National Society of Genetic Counselors. http://www.nsgc.org/. 2009.
New Jersey State Department of Health and Senior Services. Clinical Laboratory Improvement Service. http://www.state.nj.us/health/phel/clis.shtml. 2009.
New York State Department of Health. Clinical Laboratory Evaluation Program. http://www.wadsworth.org/labcert/clep/clep.html. 2009.
Secretary’s Advisory Committee on Genetic Testing. Enhancing the Oversight of Genetic Tests: Recommendations of the SACGT. Available at: http://www4.od.nih.gov/oba/sacgt/reports/oversight_report.pdf. 2007.
Secretary’s Advisory Committee on Genetics,, Health, and Society. US System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services. Available at: http://www4.od.nih.gov/oba/sacghs/reports/SACGHS_oversight_report.pdf. 2008.
Secretary’s Advisory Committee on Genetics, Health, and Society. Available at: http://oba.od.nih.gov/sacghs/sacghs_home.html. National Institutes of Health Office of Biotechnology Activities. 2009.
Social Security Act. As amended through 2007. Available at: http://www.ssa.gov/OP_Home/ssact/ssact-toc.htm.
US Government Accountability Office. Testimony before the US Senate Special Committee on Aging. Nutrigenetic Testing: Tests Purchased from Four Web Sites Mislead Consumers. Available at http://www.gao.gov/new.items/d06977t.pdf. 2006.
US Preventive Services Task Force. Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility. Available at: http://www.ahrq.gov/clinic/uspstf/uspsbrgen.htm. Agency for Healthcare Research and Quality. 2005.
US Preventive Services Task Force. Screening for Hemochromatosis. Available at: http://www.ahrq.gov/clinic/uspstf/uspshemoch.htm. Agency for Healthcare Research and Quality. 2006.
Washington State Office of Laboratory Quality Assurance (LQA). Available at: http://www.doh.wa.gov/hsqa/FSL/LQA_Home.htm. 2009.
Wasson K, Cook ED, Helzlsouer K. Direct-to-consumer online genetic testing and the four principles: an analysis of the ethical issues. Ethics Med 2006; 22: 83–91.
Wolfberg AJ. Genes on the Web–direct-to-consumer marketing of genetic testing. N Engl J Med 2006; 355: 543–545.
21 CFR Part 809 In Vitro Diagnostic Products for Human Use. Revised as of April 1, 2008. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=809. 2008.
21 CFR Part 820 Quality System Regulation. Revised as of April 1, 2008. Available at: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=820&showFR=1. 2008.
42 CFR Part 493. The Clinical Laboratory Improvement Amendments (CLIA) Regulations. As amended. Available at: http://wwwn.cdc.gov/clia/regs/toc.aspx.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Chen, B., Boone, D.J. (2010). US Oversight and Regulation of Genetic Testing. In: Kristoffersson, U., Schmidtke, J., Cassiman, J. (eds) Quality Issues in Clinical Genetic Services. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3919-4_12
Download citation
DOI: https://doi.org/10.1007/978-90-481-3919-4_12
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-3918-7
Online ISBN: 978-90-481-3919-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)